{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:08:21Z","timestamp":1768385301840,"version":"3.49.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To describe the clinical presentation of a patient with early-onset diabetes and to report a novel heterozygous\n                      <jats:italic>WFS1<\/jats:italic>\n                      variant of uncertain significance (VUS) identified in this case. This report aims to contribute to the phenotypic and genotypic spectrum of\n                      <jats:italic>WFS1<\/jats:italic>\n                      -related disorders and to discuss the challenges of interpreting VUS in complex clinical scenarios.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were collected from the proband and his family members. Whole-exome sequencing was performed on the proband. Sanger sequencing was subsequently utilized to validate the identified variant in the proband and his parents. A review of the relevant literature was also conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A previously unreported heterozygous missense variant in the WFS1 gene, c.1550G&amp;gt;C (p.Arg517Pro), was identified in the proband. Segregation analysis confirmed that this variant was inherited from his father, a non-diabetic carrier; the mother did not carry the variant. The proband\u2019s clinical phenotype was primarily characterized by early-onset diabetes and its vascular complications. No discernible neurosensory features typical of classical Wolfram syndrome\u2014such as optic atrophy, deafness, or diabetes insipidus\u2014were observed. Following the American College of Medical Genetics and Genomics (ACMG) guidelines, this variant was classified as one of uncertain significance (VUS). The classification was based on the following supporting criteria: PM2_Supporting (due to its extremely low allele frequency of 0.000077 in population databases) and PP3_Moderate (based on in silico predictions from the REVEL tool, which suggested a deleterious effect).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case report describes a novel WFS1 missense variant of uncertain significance (p.Arg517Pro) identified in a patient with early-onset diabetes. This finding contributes to the growing catalog of rare WFS1 variants and highlights the interpretive challenges they pose. It suggests that WFS1 could be considered in the genetic evaluation of selected cases of early-onset diabetes, even in the absence of full syndromic features. Prospective monitoring of asymptomatic carriers of similar variants may be warranted, pending further evidence to clarify their clinical significance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1743282","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:15:38Z","timestamp":1768367738000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel heterozygous WFS1 variant of uncertain significance in a patient with early-onset diabetes: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Wen","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-010-9350-4","article-title":"WS1 gene mutation analysis of Wolfram syndrome in a Chinese patient and a systematic review of literatures","volume":"38","author":"Yu","year":"2010","journal-title":"Endocrine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1038\/s41598-023-36334-7","article-title":"The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.09.007","article-title":"WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum","volume":"580","author":"Takei","year":"2006","journal-title":"FEBS Lett"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/ijerph19063225","article-title":"Wolfram syndrome 1: from genetics to therapy","volume":"19","author":"Rigoli","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/medicina60071064","article-title":"Wolfram syndrome type I case report and review-focus on early diagnosis and genetic variants","volume":"60","author":"Jurca","year":"2024","journal-title":"Med (Kaunas Lithuania)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05905-8","article-title":"GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models","volume":"66","author":"Gorgogietas","year":"2023","journal-title":"Diabetologia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal transduction targeted Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421055111","article-title":"A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","article-title":"GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress","volume":"4","author":"Yusta","year":"2006","journal-title":"Cell Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70114","article-title":"Characterization of novel WFS1 variants in three diabetes pedigrees","volume":"17","author":"Liu","year":"2025","journal-title":"J Diabetes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13098-025-01651-6","article-title":"GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome","volume":"17","author":"Jagom\u00e4e","year":"2025","journal-title":"Diabetol Metab Syndrome"},{"key":"B12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/gim.2012.180","article-title":"Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype","volume":"15","author":"De Heredia","year":"2013","journal-title":"Genet Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12437","article-title":"Mutation update and uncommon phenotypes in a French cohort of 96 patients with WFS1-related disorders","volume":"87","author":"Chaussenot","year":"2015","journal-title":"Clin Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3763","article-title":"Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models","volume":"14","author":"Crouzier","year":"2022","journal-title":"Sci Trans Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1743282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:15:39Z","timestamp":1768367739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1743282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":14,"alternative-id":["10.3389\/fendo.2025.1743282"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1743282","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1743282"}}